Speaker illustration

Professor Alberto Zambon

University Hospital of Padova, Padua (Italy)

Prof. Alberto Zambon MD, PhD, FAHA Associate Professor of Medicine, Department of Medicine – DIMED , University of Padua School of Medicine – Italy Affiliate Assistant Professor, of Medicine, Division of Endocrinology, Metabolism and Nutrition, School of Medicine, University of Washington, Seattle, WA, USA Professor Zambon was a Post-Doctoral Fellow in Endocrinology and Metabolism at the Division of Endocrinology, Metabolism and Nutrition, School of Medicine, University Professor Zambon is currently a member of the national board of the Italian Atherosclerosis Society Foundation. He is a member of the Italian Atherosclerosis Society (SISA), the European Atherosclerosis Society (EAS), Gold Heart Member of the AHA and FAHA, and the International Atherosclerosis Society (IAS). He has served as member of the the International Advisory Board for the XV and XVI International Atherosclerosis Society (IAS) Symposiums. Professor Zambon is currently a member of the EAS the Executive Committee.

Change of paradigm in dyslipidemia management

Event: ESC Congress 2022

Topic: Lipids

Session type: Satellite Symposium

Thumbnail

Sequential treatment strategy in dyslipidemia vs earlier use of combination therapies: decision-making factors

Event: ESC Congress 2021 - The Digital Experience

Topic: Lipids

Session type: Satellite Symposium

Thumbnail

Combination therapy in dyslipidaemia. What is new in Europe?

Event: ESC CONGRESS 2014

Topic: Epidemiology, lipids

Session type: Satellite Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk